In a press release by AbbVie, the company whose all-oral regimen for treating hepatitis C (HCV) is now in Phase III clinical study, the FDA has designated their interferon-free regimen ABT-450/r + ABT-267 + ABT-333 — with and without ribavirin — as a “Breakthrough Therapy” for…Read More
USPSTF states most Americans should be tested for HIV
The US Preventive Services Task Force announced today that nearly all adolescents and adults in the United States should be screened for HIV infection. This final recommendation was based upon a review of current research on HIV screening as well as considering the information provided by…Read More
HIV vaccine study HVTN 505 stopped early
The National Institute of Allergy and Infectious Diseases (NIAID) announced last week that it will stop the experimental vaccine injections in its HVTN 505 Phase IIb clinical study. An independent monitoring board found during an early review of the data (April 22) that the HIV vaccine…Read More
Some good news for people on ADAP waiting lists
In a statement issued today by NASTAD, the HIV drug assistance program run by Welvista will transition to a new organization called HarborPath effective May 6, 2013. The Welvista program currently helps uninsured and under-insured individuals ineligible for ADAP or on ADAP waiting lists get their…Read More
CROI2013: Experimental treatments for HIV
At this year’s Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta there were several presentations about new treatments or new treatment strategies that could benefit both those new to treatment as well as treatment veterans. Merck presented data on a new non-nucleoside reverse transcriptase (NNRTI)…Read More
Project Inform issues recommendations on using surveillance data for HIV care linkage and retention
Read the full report online. SAN FRANCISCO, April 1, 2013. Project Inform, an HIV and hepatitis advocacy and education group has published recommendations drafted by a diverse group of advocates and public health professionals guiding the use of laboratory data collected by public health surveillance agencies to…Read More
CROI2013: HIV and your heart
There were a number of presentations and posters on HIV and the heart this year at the Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta. These ranged from studies showing that a common scoring system for heart attack risk may under-estimate risk in people with…Read More